Navigation Links
Continued Demand Makes Monsanto and Agriculture Unique Investment Opportunities, Global Seeds and Traits Lead to Tell Investors
Date:3/17/2010

ST. LOUIS, March 18, 2010 /PRNewswire-FirstCall/ -- As world population growth and dietary shifts continue, Monsanto Company's (NYSE: MON) ongoing investment in agriculture is bringing more choices to the farm than ever before, Brett Begemann, executive vice president – seeds and traits, will tell investors today at the Nomura Global Chemical Leaders Conference in Dublin. Those choices will help farmers around the world meet growing global demand for grain.

"Given the projections for global population growth and increasing dietary demands, the case stands to either grow more food on more acres or increase yields on the same acreage to meet the increased need for grain," Begemann will say.  "With limited arable land, this future demand must be met through improvements in yield per acre.  Simply put, the world is going to need to produce more with less, and that's what we help farmers do."

Begemann will discuss Monsanto's target of helping farmers double 2000 yields in corn and soybeans by 2030 through technology, which has driven Monsanto's investment in biotechnology and breeding.  "Combined with the germplasm libraries and molecular markers Monsanto has developed, this has equipped the company with the tools to deliver the highest-yielding, best-performing seed," Begemann will say
'/>"/>

SOURCE Monsanto Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
2. ARRIVE Registry Analysis Demonstrates Continued Safety and Efficacy of TAXUS(R) Stent in Complex Real-World Patients
3. ProMetic reports continued positive data in PBI-1402 phase II trial in chemotherapy-induced anemia
4. Senesco Technologies Regains Compliance With Amexs Continued Listing Requirements
5. Sangui BioTech International, Inc., Reports Sales Increase, Continued Losses
6. Emisphere Reports Receipt of Notification from NASDAQ Regarding Non-Compliance with Continued Listing Requirements
7. Bioheart, Inc. Reports Receipt of Notification from NASDAQ Regarding Non-Compliance with Continued Listing Requirements
8. Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships
9. Microfluidic Systems Receives Continued Funding From the Department of Homeland Security (DHS) Toward the Commercial Production of Autonomous Airborne Pathogen Detection Systems
10. Nasdaq Grants VirtualScopics Request for Continued Listing
11. Sangui Biotech International, Inc., Reports Sales Decrease, Continued Losses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2, 2015 GOJO, inventors of PURELL ® ... antibiotic stewardship at the White House Forum.  GOJO was ... organizations and stakeholders at the White House Forum to ... the emergence of antibiotic-resistant bacteria, detect resistant strains, preserve ... spread of resistant infections. "A primary prevention ...
(Date:6/2/2015)... 2, 2015 MGB Biopharma ... resistance problem  MGB Biopharma, a biopharmaceutical ... to address the major global problem of antibiotic ... stable intravenous (IV) formulation of MGB-BP-3, designed for the ... The intravenous formulation of MGB-BP-3 is ...
(Date:6/2/2015)... LA (PRWEB) June 02, 2015 ... gene synthesis to improve protein expression, announced the formation ... includes six executives and entrepreneurs with a broad range ... industries. , The team includes: , Jimmy Roussel, ... , Roussel has a background in technology and marketing. ...
(Date:6/1/2015)... 1, 2015  Turing Pharmaceuticals AG announced that life ... , MD, MSc,  has joined the company as ... Salinas, who holds a medical degree as well ... of significant accomplishments in the pharmaceutical industry, and ... Salinas has played a leadership role in numerous ...
Breaking Biology Technology:GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 2GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 3GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 4MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 2MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 3GenoCAD Announces New Board of Advisors, Improves Protein Expression Using Custom Gene Synthesis 2GenoCAD Announces New Board of Advisors, Improves Protein Expression Using Custom Gene Synthesis 3Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 2Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 3
... Aug. 6 Advanced Life Sciences,Holdings, Inc. (Nasdaq: ... the,discovery, development and commercialization of novel drugs in ... today,announced that it will host a conference call ... on Thursday, August 14, 2008 at 10:00,a.m. (EDT). ...
... Aug. 6 Denham Capital,("Denham") announced today ... million in VitAG,Corporation ("VitAG"). VitAG technology converts ... capable of competing with and,outperforming conventional fertilizers. ... biosolids-to-fertilizer manufacturing plants., "Denham,s investment in ...
... the biometrics company enabling applications for the ... alliance with Methode Electronics, Inc. One of ... includes being a solid Tier 1 automotive ... subsystem devices. Together, Methode and Lumidigm will ...
Cached Biology Technology:Advanced Life Sciences To Host 2008 Second Quarter Financial Results Conference Call and Webcast 2Advanced Life Sciences To Host 2008 Second Quarter Financial Results Conference Call and Webcast 3Denham Capital to Invest $60 Million in VitAG, Recycler of Municipal Biosolids 2 Lumidigm Signs Strategic Agreement with Methode Electronics : Automotive Supplier Invests in Biometric Component Development 2
(Date:5/20/2015)... DUBLIN , May 20, 2015 ... Markets ( http://www.researchandmarkets.com/research/h8t4x6/5year ) has announced the ... of the Global Iris Recognition Market" ... http://photos.prnewswire.com/prnh/20130307/600769) , ,This research service analyses ... across the government and commercial sectors, ...
(Date:5/19/2015)... 2015 Research and ... of the  "Genetic Testing Market Outlook 2018" ... , ,A recent report, Genetic Testing Market ... the current and future genetic testing market. ... working principles and types are covered in ...
(Date:5/11/2015)... JOSE, Calif. , May 11, 2015 /PRNewswire/ ... developer of human interface solutions, today announced the ... Vice President and Chief Financial Officer, reporting to ... Ali replaces Synaptics, current Chief Financial Officer, ... December 2014. Mr. Ali brings ...
Breaking Biology News(10 mins):Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Global Genetic Testing Market Outlook 2018 2Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2
... University of Southampton and the Australian National University report that ... natural standards and at current rates may reach ... by 2200. The team used geological evidence of ... of natural sea-level rise. This was compared with historical tide-gauge ...
... have revealed the inner workings of the ozone hole ... chlorine in the stratosphere has not yet caused a ... years after the Montreal Protocol agreement limited human emissions ... the annual ozone hole and watched it essentially stabilize, ...
... 10, 2013 Spectrum Health will be the first ... in the nation to offer treatment with a newly ... for adult epilepsy patients whose seizures have not responded ... is an implantable therapeutic device designed to detect abnormal ...
Cached Biology News:What the past tells us about modern sea-level rise 2NASA reveals new results from inside the ozone hole 2NASA reveals new results from inside the ozone hole 3Spectrum Health to offer implantable neurostimulator for hard-to-treat epilepsy patients 2
Collected from sexually mature, mixed sex, mixed breed guinea pigs. Pricing: $120/unit for 1 - 10 units...
SEQUENASE PCR PRODUCT PRE-SEQU, 1 EA. Category: SEQUENASE....
Mouse monoclonal [IFR0104] to Salmonella enteriditis ( Abpromise for all tested applications)....
All serum is collected from adult animals aged 6 months or older. Certified U.S. orgin. Pricing: $35/unit for 1 - 10 units...
Biology Products: